Browse by UCL Departments and Centres
![]() | Up a level |
Group by: Author | Type
Number of items: 13.
H
| Haig, A and Dozier, M and Liu, D and McKendree, J and Roper, T and Selai, C (2005) METRO taxonomy - progress report on assessment. MED TEACH , 27 (2) 155 - 157. 10.1080/01421590500091102. |
| Hamandi, K and Haddadi, AS and Liston, A and Laufs, H and Fish, DR and Lemieux, L (2005) fMRI temporal clustering analysis in patients with frequent interictal epileptiform discharges: Comparison with EEG-driven analysis. NEUROIMAGE , 26 (1) 309 - 316. 10.1016/j.neuroimage.2005.01.052. |
| Hamandi, K and Laufs, H and Salek-Haddadi, A and Liston, A and Duncan, J and Fish, D and Lemieux, L (2005) Functional MRI of generalised spike wave activity. In: EPILEPSIA. (pp. 176 - 177). BLACKWELL PUBLISHING |
P
| Pillas, D and Selai, C (2005) Economic aspects of epilepsy and antiepileptic treatment: a review of the literature. Expert Rev Pharmacoecon Outcomes Res , 5 (3) 327 - 338. 10.1586/14737167.5.3.327. |
R
| Remak, E and Hutton, J and Selai, CE and Trimble, MR and Price, MJ (2005) A cost-utility analysis of adjunctive treatment with newer antiepileptic drugs in the UK. Journal of Medical Economics , 7 29 - 40. |
S
| Schrag, A and Selai, C and Quinn, N and Hobart, J (2005) Measuring health-related quality of life in patients with progressive supranuclear palsy. NEUROCASE , 11 (4) 246 - 249. 10.1080/13554790590963068. |
| Schrag, A and Selai, CE (2005) Quality of life assessment in atypical parkinsonian disorders. In: Litvan, I, (ed.) Atypical Parkinsonian Disorders: Clinical and Research Aspects. (277 - 286). Humana Press: Totowa, New Jersey. |
| Schrag, AE and Selai, C and Lees, AJ and Quinn, NP and Litvan, I and Lang, AE (2005) The PSP QoL (PSP-QoL): A validated, patient-based outcome measure for progressive supranuclear palsy. In: MOVEMENT DISORDERS. (pp. S104 - S104). WILEY-LISS |
| Selai, C and Bannister, D and Trimble, M (2005) Antiepileptic drugs and the regulation of mood and quality of life (QOL): The evidence from epilepsy. EPILEPSIA , 46 50 - 57. |
| Selai, CE and Trimble, MR and Price, MJ and Remak, E (2005) Evaluation of health status in epilepsy using the EQ-5D questionnaire: a prospective, observational, 6-month study of adjunctive therapy with anti-epileptic drugs. CURR MED RES OPIN , 21 (5) 733 - 739. 10.1185/030079905X43695. |
| Silveira-Moriyama, L and Evans, AH and Katzenschlager, R and Lees, AJ (2005) Correlation between punding and dyskinesias in Parkinson's disease (PD). In: MOVEMENT DISORDERS. (pp. S133 - S133). WILEY-LISS |
| Silveira-Moriyama, L and Goncalves, LR and Chien, HF and Barbosa, ER (2005) Botulinum toxin a in the treatment of blepharospasm - A 10-year experience. ARQ NEURO-PSIQUIAT , 63 (2A) 221 - 224. 10.1590/S0004-282X2005000200006. |
| Silveira-Moriyama, L and Williams, D and Katzenschlager, R and Lees, AJ (2005) Pizza, mint, and licorice: Smell testing in Parkinson's disease in a UK population. In: MOVEMENT DISORDERS. (pp. S139 - S139). WILEY-LISS |


